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3D-structureures of the HIV-1 subtype B epidemic in Brazil is the high frequency of isolates
exhibiting tryptophan (W) in the tetramer (GWGR) at the tip of the V3 loop. We observed that the
frequencies of glutamic and aspartic acids at site 25 of the V3 loop are quite distinct in GWGR isolates
compared with viruses with other tetramers. The basic amino acids at sites 11 and 25 of V3 are strongly
linked with CCR5-to-CXCR4 coreceptor shift. We therefore predicted phenotype usage and found that GWGR
isolates are exclusively CCR5-using. Further evidence of this came from intrahost sequences, where basic
amino acid substitutions at sites 11 and 25 emerged only in isolates presenting a tryptophan-to-glycine
replacement at the tetramer of the V3. In addition, modeled 3D-structures of the V3 loop of GWGR and GGGR
in intrahost viruses differ essentially in the binding region of the coreceptor.
© 2008 Elsevier Inc. All rights reserved.Introduction
Infection with HIV-1 is primarily seen in CD4+ T cells and
macrophages, although other cell types can also be infected. The
cellular tropism is essentially determined by a series of interactions
between the viral envelope glycoprotein (Env) and cell receptors. To
enter target cells, HIV-1 typically needs to recognize and bind two
membrane receptors. These events are perhaps the most crucial for
HIV-1 infection, initially involving the interaction of the envelope with
the main receptor (CD4) and thenwith chemokine coreceptors (Berger
et al., 1999; Boyd et al., 1993; Wu et al., 1996). The envelope is a
noncovalently associated trimeric glycoprotein composed of surface
(gp120) and transmembrane (gp41) subunits (Roux and Taylor, 2007).
The envelope interaction with the cell surface causes conformational
changes in the viral glycoprotein. It is thought that, following the
binding of gp120 to CD4, conformationalmodiﬁcations enable the gp41
subunit to interact with the cell membrane, thereby allowing the virus
to enter the host cell (Wei et al., 2003). The V3 region of gp120 plays a
fundamental role in various characteristics of HIV. For example, upon
HIV infection, there is an immunodominant antibody response directed
primarily against the V3 region (Frost et al., 2005). In addition to virus–
cell binding, the V3 region also determines which of two chemokine
coreceptors (CCR5 or CXCR4) will be exploited for entry (Choe et al.,
1996; Coakley et al., 2005; Rizzuto et al., 1998). In roughly 50% of all2130/5579 8226.
l rights reserved.infected individuals, the virus changes its chemokine receptor usage
during the progression of HIV-1 infection (Boyd et al., 1993; Schuite-
maker et al., 1992). In the early phase of HIV-1 infection, the viruses
isolated are typically the R5 variants, which present tropism for the
CCR5 receptors, whereas the X4 variants, which preferentially use the
CXC4 receptors, emerge later in the infection. In the late phase of HIV-1
infection, the intrahost viral population can present a variety of
compositions; it can be composed exclusively of X4 variants, it can
consist of variants capable of using both coreceptors (R5X4 variants), or
it can present equal numbers of the R5 and X4 variants (Kuiken, 1999;
Scarlatti et al., 1997; Shioda et al., 1991).
In European and North American countries, HIV-1 infection has
been well characterized and involves a predominance of subtype B
strains. In Brazil, subtype B also prevails in the HIV-1 epidemic,
although nearly half of the infections caused by the subtype B strain are
due to viruses with the unusual GWGR motif in the V3 loop of the env
gene. Although GW viruses have sporadically been observed in other
countries, such as China, France, the Czech Republic, the Philippines,
and Cuba, high frequencies of GW isolates are seen only in Brazil. This
suggests that the presence of tryptophan (W) at the tip of the V3 loop,
although rare in other countries, is not deleterious to HIV-1. Previous
studies have demonstrated that the GW and GP viruses are not
phylogenetically distinguishable (Kuiken, 1999; Meng et al., 2002;
Morgado et al., 1994; Potts et al., 1993; Santoro-Lopes et al., 2000),
whereas theHIV-1 subtype B found inThailanddiffers from the subtype
B isolates of other regions in terms of their tetramers (Kuiken, 1999).
Nevertheless, the evolutionary mechanisms responsible for the fact
Fig. 1. Amino acid frequencies in the V3 loop of HIV-1. Consensus sequences of GW viruses (panel A) and viruses with other motifs (i.e., GP, GF, GL, etc) at the V3 loop (panel B) are
within the dark grey area, and the V3 loop tetramer is underlined. Below each nonconserved site, the speciﬁc frequencies of the most common residues are depicted. The alternative
amino acids are indicated above the sites of consensus sequences; the number above each residue represents its occurrence in the data set. The numbers inside the parentheses
indicate sites 11 and 25, which are important for the R5-to-X4 coreceptor shift. Arrows indicate sites where the two consensuses differ.
able 1
requencies of aspartic (D) and glutamic (E) acids at site 25 of the V3 loop of HIV-1
Fisher's two-tailed probability calculated in 2×2 contingency tables.
These sequences together with their coreceptor preference status were obtained from
e HIV Sequence Database (http://hiv-web.lanl.gov).
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epidemics have yet to be explored. Therefore, we focused on diverse
aspects of the evolution of the GWand GP isolates of subtype B viruses
co-circulating in Brazil during a speciﬁc period (1983–2000).
We found that the frequencies of amino acids at sites of the V3 loop
linked with CCR5-to-CXCR4 shift are quite distinct between the GW
and GP viruses. Additionally, GW viruses may use the CCR5 coreceptor
exclusively, according to the predicted phenotype based on the V3
sequences. Lastly, the modeled 3-D structure of the V3 loop of the GW
and GG variants from intrahost samples differs mostly in the binding
region of the coreceptor.
Results
Amino acid composition at the V3 loop
In order to characterize HIV-1 variants, we analyzed the amino acid
substitutions in the V3 loop on a site-by-site basis. Fig. 1 depicts the
consensus sequences and the alternative amino acids obtained from
the alignments of GWGR viruses and subtype B viruses with other
tetramers at the tip of V3 loop (e.g., GPGR, GFGR, GGGR, etc). In
addition to the second V3 tetramer site, consensuses also differed at
sites 14 and 25 (arrows in Fig. 1). Although a limited number of
sequences were analyzed, both viruses presented an extensive
number of amino acid substitutions throughout the V3 region. This
was expected, since the V3 region has been characterized as one of the
most diverse regions of the HIV-1 genome. Most of the sites were
highly variable, although a great number of the substitutions observed
were due to singleton mutations. Equally, in GWGR viruses and
subtype B isolates with other tetramers (GXGX), many V3 sites
contained a variety of single amino acids. Notably, some amino acids
presented at high frequencies, whereas others were unique substitu-
tions. For example, at site 29, the aspartic acid-to-asparagine
substitution reached a high frequency in both viruses, while othersubstitutions, such as aspartic acid-to-glutamic acid, were less
common. This is probably due to the genetic barrier of the ancestral
sequence, since replacement of aspartic acid to asparagine involves
only one G-to-A transition while the replacement to glutamic acid
requires at least one transversion (i.e., GAT-to-GGA or GAC-to-GAA/
GAG). In contrast, at site 14, the proportions of methionine, leucine,
and isoleucine were, respectively, 61%, 29%, and 10% in GWGR viruses,
compared with 29%, 13%, and 54% in GXGX viruses. Although the
substitution methionine-to-isoleucine involves only one transition at
the third site of the triplet (i.e., ATG-to-ATA), the genetic barrier
cannot be evoked to explain why the most frequent amino acid at site
14 of the V3 loop of GWGR viruses is methionine, while in GXGX
viruses, it is isoleucine (Fig. 1).
Proportions of aspartic and glutamic acid at site 25 of the V3 loop
The most noticeable dissimilarity between the GWGR and GXGX
viruses was in the proportions of aspartic acid (D) and glutamic acidT
F
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Fig. 2. Prediction of coreceptor usage of HIV-1. The medians of PSSM scores of the GWGR (n=41), GXGX (n=78), R5 (n=268), and X4 (n=56) data sets are depicted as ﬁlled squares.
Boxes depict 25–75% intervals of PSSM scores values. Higher PSSM scores are indicative of CXCR4-using viruses. The R5 and X4 sequences and their coreceptor preference status were
obtained from the HIV Sequence Database (http://hiv-web.lanl.gov).
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acids at site 25 has been implicated in the better replicative ﬁtness of
HIV-1 R5-using strains (da Silva, 2006; Hung et al., 1999). Conse-
quently, for comparative purposes we also analyzed 268 sequences of
R5-using viruses and 56 sequences of X4-using viruses with known
coreceptor status obtained from the Los Alamos HIV database (http://
hiv-web.lanl.gov). Likewise, a great variety of amino acids were
observed at site 25 of the HIV-1 V3 loop, and, in most viruses, aspartic
acid and glutamic acid was present in high proportions. Equivalent
quantities of the ratio of aspartic acid to glutamic acid (D:E) were
observed between the GXGX and X4 viruses (p=0.629, Table 1).
However, the overall quantity of aspartic acid plus glutamic acid (D+E)
in the GXGX viruses was roughly 73%, whereas in the X4 viruses it
comprised only 41% of the amino acids found at site 25. The fact that
the quantities of aspartic acid and glutamic acid observed in the GXGX
virus and the X4 variant were similar (1:1) might indicate that the two
acids have a comparable impact on the ﬁtness of HIV-1. On the other
hand, in the GWGR and R5 viruses there is an imbalance in the
proportion of aspartic and glutamic acids at site 25 of the V3 loop. For
example, the quantity of glutamic acid was disproportionately high
(23/41) in the GWGR viruses compared to the proportion of glutamic
(26/78) in the GXGX viruses (p=0.007, Table 1), indicating that the
alternative amino acids might be detrimental to the GWGR viruses.
Conversely, in the R5 viruses the quantity of aspartic acid at site 25
was high (182/268) in comparisonwith the proportion of aspartic acid
(11/56) observed in the X4 viruses (p=0.001, Table 1).
Predicted coreceptor usage
We noticed some differences regarding the frequencies of amino
acids at sites 11 and 25 of the V3 loop region between the GWGR and
GXGR viruses since these sites are linked with CCR5-to-CXCR4
coreceptor shift. We were then interested in determining whether
this distinction between the two viruses was also observed in the
context of corereceptor usage, as predicted by the position-speciﬁc
scoring matrices (PSSM) method. To that end, we determined the
PSSM score for each sequence of the GWGR and GXGR viruses usingthe x4r5 matrix (Jensen et al., 2003). We also determined the PSSM
scores of 268 sequences of R5 viruses and 56 sequences of X4 viruses.
The overall PSSM scores of the GWGR, GXGX, R5, and X4 data sets are
plotted in Fig. 2. The medians, 25–75% intervals, and range of non-
outliers for the GWGR, GXGX, and R5 viruses have negative values that
did not differ signiﬁcantly between these data sets. On the other hand,
the X4 viruses have positive values that are signiﬁcantly distinct from
the other data sets. This is expected because high PSSM scores are
indicative of CXCR4-using viruses. In this context, we detected six
isolates (6/78) of the GXGX data set with high PSSM scores (open
diamonds in Fig. 2) that are within the non-outlier range for the X4
viruses, therefore suggesting that these isolates are CXCR4-using
viruses.
Intrahost analysis of the V3 loop
The above analyses were performed on sequences from unlinked
individuals (interhost) and therefore reveal the evolution of GW
viruses at the population level. To further our understanding of the
evolution of GW viruses during intrahost infection, we studied
sequences of a region of the env gene from an HIV-1-infected patient.
These sequences were from molecular clones sampled during
antiretroviral therapy, and again at 2 weeks and 12 weeks after
structured therapy interruption. In a previous study, we noted that
complete discontinuation of therapy-induced recrudescence of wild-
type drug-sensitive viruses (Silva et al., 2006). Speciﬁcally, drug-
resistant viruses with a GGGR tetramer at the tip of the V3 loop
predominated during antiretroviral therapy, whereas at 12 weeks
after the interruption of therapy, the intrahost population was
completely replaced by viruses presenting the GWGR tetramer at
the tip of the V3 loop. However, the less glycosylated pattern of X4
variants has been associated with structural modiﬁcation of the V3
loop region during coreceptor shift (Ogert et al., 2001). Our intrahost
analysis indicated that the GW sequences presented a lower
proportion of N-linked glycosylation sites than did the GG sequences.
In the GW sequences, the proportions of N-linked glycosylation,
speciﬁcally at two sites prior to the V3 loop, were 60% and 50%,
225É. Leal et al. / Virology 381 (2008) 222–229respectively, comparedwith 100% at both sites in the GG sequences. In
addition, the GG sequences also presented basic amino acids at sites 11
and 25 of the V3 loop that typically confer the status of CXCR4-using to
HIV-1. In contrast, the GW sequences had an uncharged (serine) and
negative amino acid at V3 loop sites 11 and 25, respectively.
Intrahost V3 loop evolution
For the intrahost HIV-1 population, the phylogenetic analysis
revealed a clearer scenario concerning the dynamics of the GW and
GG variants. As can be seen in Fig. 3, the maximum a posteriori (MAP)
phylogenetic tree shows that the GW sequences formed two clusters
located near the root, whereas the GG sequences formed a unique and
well-deﬁned cluster distant from the root. We also used themaximum
likelihood approach to reconstruct the ancestral sequences of this
intrahost population. This reconstruction (based on a midpoint rooted
MAP tree) showed that the most recent common ancestral (MRCA)
virus of the intrahost population most likely had a GWGR tetramer at
the tip of the V3 loop (Fig. 3). In addition, the reconstructed ancestral
states showed an extensive number of amino acid substitutions,
including basic amino acids, at sites 11 and 25 (sites 30 and 44,
respectively, in our alignment), that emerged only in the lineage of GG
viruses. Notably, most of the changes in the GG lineage, including anFig. 3. Phylogenetic tree of intrahost viruses. Maximum a posteriori tree of HIV-1 from seque
The numbers above the branches indicate the posteriori probability support for each cluste
reconstruction of amino acid substitutions that occurred in the lineages are indicated by one-
The dotted area indicates amino acid changes with residues inside the V3 loop region. The site
replacement in the V3 loop tetramer. The sequence B.US.98.1058_11 (AY331295) was used aincrease in the number of positive charged amino acids, occurred
within the V3 loop.
Modeled structure of GW and GG V3 loop
To gain additional insights about the changes associated with the
GWGR to GGGR shift, we evaluated the characteristics of the three
dimensional (3D) structure of the V3 loop predicted from these
variants. To construct the 3Dmodels, we used the ancestral sequences
previously reconstructed with ML analysis. Initially, a blast search was
performed in order to identify the best template structure. The best-
scored structure was from Gp120 of the HIV-1 JR-FL variant
(PDB=2b4c). Next, we extracted the V3 loop region from the 2b4c
structure and used it as a backbone template to model the side chains
of the GW and GG ancestral sequences. Our modeled structures were
quite similar to the 2b4c template, and the quality of thesemodels was
evaluated by comparing the Ramachandran plot of the V3 loop of the
template with plots of the GW and GG structures (data not shown).
The V3 loop structure of the GW and GG variants indicated that they
were similar to each other, and differences in the structure were due
to side chains of some amino acids, such as the tetramer at the tip of
the V3 tetramer (grey region in Fig. 4). Additionally, the most striking
difference between the V3 structures of the GW and GG variants wasnces of an individual infected by GWGR lineage that later was replaced by a GGGR virus.
r of the tree. Grey areas indicate the main clusters. (A) Maximum likelihood ancestral
letter amino acid code, along with the position in the alignment and the charge residues.
s 11 and 25 of V3 are underlined. The arrow indicates the tryptophan (W)-to-glycine (G)
s outgroup.
Fig. 4. Structures of the V3 loop of GWGR and GGGR variants. Models of 3-D structures of the V3 loop of ancestral sequences of GWGR and GGGR variants from intrahost samples are
depicted (panels A and B, respectively). The models were based on the Gp120 structure of a HIV-1 subtype B isolate (PDB=2b4c). The tetramer at the tip of the V3 loop is depicted in
grey, and the hydrophilic base of coreceptor-binding region (N6N7) is depicted in green in the structures. The replacement from asparagine (N) to lysine (K) at site 7 of V3 is also
depicted inmagenta (panel B). Likewise, replacement of Glycine (G) to Glutamic (E) at site 24 of the V3 loop in the GG variants is depicted in cyan (Panel B) in the binding pocket of the
V3 structure. Sites 11 and 25 of V3 usually linked with CCR5-to-CXCR4 coreceptor shift are also depicted (yellow) in the structures.
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the V3 loop in Fig. 4). This region has a hydrophilic base formed by
uncharged asparagines at sites 6 and 7 of the V3 loop (depicted in
green in Fig. 4), where CCR5 binds and interacts predominantly with
the asparagine at site 7 (N7) (Huang et al., 2007). In our case, the side
chains of amino acids found in the V3 loop of the GG variants had a
great impact on the structure of the pocket region. For example, the
side chain of glutamic acid (E) at site 24 of the V3 loop found in the GG
variants partially occluded the binding pocket (cyan in panel B of Fig.
4). Interestingly, a replacement from asparagine (N) to lysine (K) at site
7 of the V3 loop was observed in the GG variants (magenta in panel B
of Fig. 4), which could completely abrogate CCR5 binding.
Discussion
Our study indicates that the GWGR and GXGX viruses were quite
distinct in terms of the frequencies of amino acids at V3 sites 14 and 25
(Fig. 1). The amino acid most frequently identiﬁed at site 14 of the
GWGR viruses was methionine (61%), whereas, in the GXGX viruses,
that distinction was held by isoleucine (54%). This disparity between
the GWGR and GXGX viruses in terms of the proportions of
methionine and isoleucine might be related to the founder effect,
and the impact that such a disparity has on the ﬁtness of HIV-1 might
be irrelevant, since the two amino acids share the same hydrophobic
characteristics. However, the differences at site 25 might have a
signiﬁcant impact on viral replicative ﬁtness. Speciﬁcally, the ﬁtness
effect of different amino acids at site 25 of the V3 loop of HIV-1
subtype B has been demonstrated by site-directed mutagenesis in R5
variants (Hung et al., 1999). This study showed that, at site 25, the
residues that were the most advantageous for virus infectivity were
aspartic acid and glutamic acid, whereas hydrophobic amino acidsdrastically reduced the ﬁtness of HIV-1. In addition, a strong relation-
ship has been demonstrated between viral infectivity and the
frequency of certain amino acids at site 25 of the V3 loop in R5
variants of HIV-1 (da Silva, 2006). Furthermore, the most common
amino acid at site 25 of the V3 region (aspartic acid) is associated with
the highest level of viral infectivity (da Silva, 2006). Consequently,
aspartic acid provides the best replicative ﬁtness for R5 variants of
HIV-1. Moreover, the second most common amino acid at site 25
(glutamic acid) is also associated with high levels of viral infectivity;
however, its selection coefﬁcient, relative to aspartic acid, is 0.18 (da
Silva, 2006). This means that viruses presenting glutamic acid at site
25 of the V3 loop in R5 variants are 18% less ﬁt than those presenting
aspartic acid at the same site.
The high variability of the V3 region has been extensively
described, and positive selection has been implicated in the main-
tenance of such diversity, in individuals as well as at the population
level (Leal et al, 2007; Lemey et al., 2007; Shankarappa et al., 1999;
Yang et al, 2003). The source of this selective pressure has also been
extensively studied. It is likely that the principal force driving the
evolution of the V3 region of HIV-1 is cell receptor usage, escape from
host immune response, or a combination of the two (Ross and Rodrigo,
2002; Williamson, 2003). In particular, coreceptor usage (i.e., CXCR4
usage) has been implicated as the main cause of the high diversity
observed at site 25 of the V3 loop (da Silva, 2006). In GWGR viruses,
the proportions at site 25 are 56% (23/41) for glutamic acid and only
17% (7/41) for aspartic acid, clearly indicating that glutamic acid is the
amino acid preferred by these viruses. In contrast, in R5 viruses,
aspartic acid is by far the most frequent amino acid (68%; 182/268) at
site 25 of the V3 loop. Equal balance between the proportion of
aspartic acid and glutamic (D:E) acid was observed in the GXGX
viruses and X4 variants (Table 1). Interestingly, the proportion of
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(57/78) of the total amount of amino acids observed at site 25 of the
V3 loop, but in the X4 viruses, the proportion was 41% (23/56). The
lower proportion of aspartic and glutamic acids in the X4 variant is in
agreement with the observation that the R5-to-X4 shift is accom-
panied by basic mutations at sites 11 and 25 of the V3 loop, the so-
called 11/25 rule. However, if the glutamic acid–aspartic acid
equilibrium is principally driven by selection based on coreceptor
usage, then both acids are equally advantageous at site 25. Therefore,
the different replicative ﬁtness reported by da Silva (2006) might be
neglected in HIV-1, since glutamic and aspartic acid are maintained at
high frequencies in GXGX viruses and X4 variants. In addition, the
imbalance in favor of glutamic acid at site 25 in GWGR viruses might
indicate distinct preferences in coreceptor usage by viruses with W at
the tip of V3 loop. Alternatively, immune pressure exerted on GWGR
viruses could differ drastically from that observed in GXGR viruses;
however, since the GWGR and GXGX viruses are co-circulating in the
same host population, it is unlikely that these viruses would elicit
distinctive host responses to the infection.
The intrahost samples showed that HIV-1 variants containing
basic mutations at sites 11 and 25 also replaced the larger tryptophan
with the tiny glycine. Although the GG viruses were not empirically
characterized by their coreceptor usage, the presence of basic amino
acids at both sites typically confers HIV-1 X4 phenotype status (De
Jong et al., 1992). An additional feature that is considered a strong
selective pressure is the variation outside epitopes at N-linked
glycosylation sites mediated by humoral immune escape antibody
attack: the glycan shield mechanism (Wei et al., 2003). During the
initial phase of HIV-1 infection, the virus needs to escape the
antibody attack, and this is achieved by acquisition of mutations at
N-linked glycosylation sites, resulting in structural modiﬁcations at
the surface of sugar moieties on the viral envelope. These mutations
permit the HIV to avoid the neutralizing antibodies in order to bind
to the viral surface proteins, thus allowing the virus to escape from
the humoral immune surveillance (Dacheux et al., 2004). Although
this mechanism is not directly associated with viral diversiﬁcation, it
is strongly linked to host immune pressure. In addition, we became
interested in this issue because the reduced glycosylation in the X4
variants had been associated with the structural modiﬁcation of the
V3 loop during the coreceptor shift (Ogert et al., 2001). The
proportion of N-linked glycosylation sites also changed with the
emergence of GG viruses. It has been demonstrated that this sort of
modiﬁcation within or near variable regions of the env gene affects
HIV-1 coreceptor usage and cell tropism (Ogert et al., 2001).
Consequently, the amino acid modiﬁcations observed in our analysis
might be linked to the R5-to-X4 shift.
Binding of gp120 to CD4 also causes conformational modiﬁcations
that project the V3 loop to interact with the cell coreceptor, and this
protrusion renders the V3 loop ﬂexible in order to interact with the
coreceptor (Hung et al., 1999; Kwong et al., 1998). It has been shown
that intrahost evolution of the V3 loop structure is highly diverse and
structurally ﬂexible throughout the infection (Watabe et al., 2006).
Therefore, structural modiﬁcations seem to be related to immune
pressures and interactions with the cell coreceptor (Sander et al.,
2007). Indeed, monoclonal antibodies directed against the D19
epitope within the V3 region neutralize only the X4 variants (Lusso
et al., 2005). Consequently, inaccessibility of this antibody to R5 might
indicate that there are signiﬁcant V3 loop conformational differences
between these two variants (Sander et al., 2007). In fact, it has been
demonstrated that intricate electrostatic interactions occur among
amino acid residues in order to preserve the proper tertiary structure
of the V3 loop (Rosen et al., 2006). This sort of structural modiﬁcation
was also observed in our intrahost analysis, where the 3D-structures
of V3 in the GW and GG variants differ primarily in the coreceptor-
binding pocket region. Furthermore, it has been demonstrated that
CCR5 interacts with the conserved sequence (P4N5N6N7) of the V3loop, and that binding of this coreceptor is blocked when N7 is
replaced by charged amino acid (Huang et al., 2007). Similarly, our
intrahost analysis also showed that the polar asparagine (N) at site 7 of
the V3 loop was replaced by a positive lysine (K) in the GG variants.
The results of the present study show that the composition of
charged amino at sites 11 and 25 of the V3 loop is quite distinct
between the GWGR and GXGX viruses. Consequently, the coreceptor
preference of these viruses might be equally affected. In addition, our
intrahost analysis showed that basic residues were present at sites 11
and 25 of the V3 loop only when tryptophan at the GWGR tetramer
(GW viruses) was replaced by glycine in the GG viruses. GWGR isolates
were characterized by a shortage of basic amino acids at sites 11/25 of
the V3 loop and by the absence of X4 variants based on the phenotype
prediction. In addition, 3D models of intrahost viruses showed
structural changes in the CCR5 binding pocket region when the
tryptophan at the tip of V3was replaced by a glycine in variants within
the host. Although we have analyzed a limited number of sequences
and the tryptophan replacement was observed in only one individual,
our ﬁndings suggest that there are constraints on the envelope of HIV-
1 to use the CXCR4 coreceptor in strains with the GWGR tetramer at
the tip of the V3 loop. Consequently, one way to maintain the proper
tertiary conformation and to use the CXCR4 coreceptor would be the
replacement of the tryptophan.
Finally, our results belie the concept that GWGR viruses are less
pathogenic, based on the rate of disease progression, than are other
subtype B strains in Brazil (Santoro-Lopes et al., 2000). Since X4
variants are generally associated with a rapid decline in CD4+ cell
counts and accelerated progression to AIDS (Schuitemaker et al., 1992;
Shankarappa et al., 1999), any comparisons between the GWGR and
GPGR viruses should incorporate the proﬁle of coreceptor usage. The
potential pitfall resides in the fact that GWGR viruses might only have
R5 variants, whereas GPGR viruses might have R5 and X4 variants
indiscriminately. Consequently, there will be a bias promoting the
incorrect notion that infectionwith a GPGR virus results in lower CD4+
cell counts or more rapid progression to AIDS than does infectionwith
a GWGR virus.
In summary, we thoroughly analyzed sequences of HIV-1 subtype B
with the GWGR tetramer at the tip of the V3 loop from viruses
circulating in Brazil. We ﬁnd a considerable difference between the
GWGR and GXGX viruses in terms of the amino acid proﬁle in the V3
region, particularly at sites 11 and 25, which are associated with the
R5-to-X4 coreceptor shift. Notably, the scarcity of basic amino acids at
sites 11 and 25 within the V3 loop of GWGR viruses might indicate
limited usage of the alternative coreceptor. Further evidence of the
constrained use of the CXCR4 coreceptor by the GWGR viruses came
from our intrahost analysis, in which the tryptophan in the tetramer
was found to be replaced byglycine only in isolateswith X4 amino acid
proﬁles (i.e., basic amino acids at sites 11 and 25 of the V3 loop). In view
of these facts, we hypothesize that the V3 loop of GWGR viruses might
prevent the electrostatic interaction of charged amino acids necessary
to maintain the proper V3 loop structure after coreceptor binding.
Materials and methods
Samples
The informed consent for collecting blood samples and the protocol
of this study was approved by the Federal University of São Paulo. We
generated 41 sequences from GWGR viruses and 78 sequences from
GXGR viruses, all taken from a 219-bp fragment of the V3 region of the
env gene (gp120) of HIV-1. These sequences were all taken from
Brazilian individuals clinically asymptomatic, naïve to drug therapy,
and with CD4 levels above 200 cells/mm3. The samples were collected
between1983 and2000. The remaining sequenceswere obtained from
the HIV Sequence Database (http://hiv-web.lanl.gov). We also ana-
lyzed 32 sequences; these were obtained over time from a single
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270-bp fragment of the V3 region of HIV-1 subtype B, sampled during
antiretroviral therapy and again at 2 weeks after and 12 weeks after
structured therapy interruption. These fragments of the V3 region of
the env gene (gp120) of HIV-1 were ampliﬁed and sequenced using
primers and conditions previously described (Silva et al., 2006).
Sequence alignment
The sequences were initially aligned using the ClustalX program
(Thompson et al., 1997). All sites with deletions and insertions were
then excluded in order to preserve the reading frames of the genes.
After this editing process, the sequences were manually aligned using
the SE-AL program, version 2.0 (http://evolve.zoo.ox.ac.uk/software/).
Prediction of coreceptor usage
In addition to the presence of basic amino acids at sites 11 and 25 of
the V3 loop (11/25 rule), we also used the position-speciﬁc scoring
matrices (PSSM)method to analyze our sequences (Jensen et al., 2003).
The PSSM detects nonrandom distributions of amino acids in a set of
sequences that may be associated with some empirically determined
property (for example, coreceptor usage) and constructs a matrix. The
matrix is thenused to compare the amino acids of query sequences and
PSSM assigns scores to each query sequence. Consequently, these
scores can be used to predict the likelihood of a query sequence having
the property of interest. We predicted the coreceptor usage of our
sequences using a PSSMmatrix (x4r5) constructed with the V3 region
of HIV-1 subtype B with a known X4 or R5 phenotype (http://
mullinslab.microbiol.washington.edu/computing/pssm/). In this con-
text, high scoring sequences are more likely to use the CXCR4
coreceptor, whereas low scoring sequences are more likely to use the
CCR5 coreceptor.
Proportion of N-linked glycosylation sites
The N-linked glycosylation sites were determined by identifying
the NX[ST]Y pattern (where X can be any amino acid). Amino acids,
such as proline, in the X or Y position can be important determinants
of N-linked glycosylation efﬁciency (Zhang et al., 2004). The analyses
were performed using the web interface available at http://www.hiv.
lanl.gov/content/hiv-db/GLYCOSITE/glycosite.html.
Phylogenetic inference
To infer the intrahost phylogenetic tree, we used Bayesian
inference, assuming GTR and a gamma correction model, as is
implemented in the MrBayes program, version 3.1.2 (Huelsenbeck
and Ronquist, 2001). For this analysis, two independent Markov chain
Monte Carlo (MCMC) were run for 107 generations with the initial 10%
of each run discarded as burn-in. The convergencewas evaluated using
the TRACER software, version 1.2 (http://beast.bio.ed.ac.uk/), and runs
were acceptedwhenall parameters presented the effective sample size
number (ESS) greater than 100. The ancestral reconstruction of the V3
loop sequence used the model 2 (M2: selection) that allows different
proportions of conserved sites (dN/dS (ω)=0), neutral sites (ω=1), and
an additional class of sites, with itsω ratio (which can be N1) estimated
directly from the data. We then mapped the inferred sites on the
phylogenetic intrahost tree. This reconstruction was performed using
the CODEMLprogram from the PAMLv. 3.14 package (Yanget al., 2000).
3-D structure prediction
Ancestral reconstructed sequences from intrahost samples were
used to build the V3 structures of the GWGR and GGGR viruses. In order
to identify structural homologues in the protein data bank (http://www.pdb.org), we used sequences of 35 amino acids (V3) and performed psi-
BLASTsearches using theMeta-Sever at Centre de Biochimie Structurale
(http://bioserv.cbs.cnrs.fr/HTML_BIO/frame_meta.html). Based on
these searches, the structure 2b4c, corresponding to the protein
Gp120 of a HIV-1 CCR5-using variant, was retrieved, and from this
structurewe then extracted theV3 loop region in theG chain andused it
as a template to build themodels. The C-α backbone of the 2b4cV3 loop
structure was used to model the side chain coordinates of the ancestral
sequences of the GWGR and GGGR variants from intrahost samples of
HIV-1 using the SCRWL software (Canutescu et al, 2003). Visualization
and editing of the structures were done using the PyMOL software
(http://www.pymol.org).
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